Archives

by in
Entry Author Date Location
San Diego’s PharmAkea Raises Capital, Forms Alliance with Celgene 10/07/13 San Diego
Sutro Aims to Deliver Anti-Tumor “Warheads” More Precisely 10/01/13 San Francisco
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww? 09/30/13 National
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
Foundation Medicine Scores $106M in Upsized IPO 09/24/13 Boston
The Best Biotech Graduate Schools in Real Life 09/23/13 National
East Coast Life Sciences Roundup: NY Genome Center, Acceleron, Bind, & More 09/20/13 Boston
Acceleron Prices Upsized IPO at $15 Per Share, Begins Trading Thursday 09/19/13 Boston
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Investors to Get $300M as FDA Approves Celgene Drug For Pancreatic Cancer 09/06/13 New York
Starting a Company Is Hard. Good Health Insurance Makes It Easier. 08/30/13 Boston
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
East Coast Life Sciences Roundup: Mana, Medivizor, Regado, & More 08/23/13 New York
Join Us, and Boston’s “Life Science Disruptors,” on Oct. 2 08/21/13 Boston
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
East Coast Life Sciences Roundup: Epizyme, Rodin, Ophthotech, & More 08/16/13 Boston
Epizyme Execs Share the Secret to a Successful IPO: PowerBars 08/15/13 Boston
East Coast Life Sciences Roundup: KiiLN, Celgene, Acceleron, & More 08/09/13 New York
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Foundation Medicine Lays Groundwork For $86M IPO 07/29/13 Boston
Array to Receive $11M From Celgene as Part of New Development Deal 07/29/13 Boulder/Denver
Celgene Nabs Option to Buy Acetylon for More Than $1.7B 07/29/13 Boston
Agios Rockets to $29 Per Share in Market Debut 07/24/13 Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Forma, CRT Deal Part of Broader Research Initiative 07/09/13 Boston
Page 4 of 9 « previous page · next page »